Additionally, an Irish study [133] found that high first trimester adiponectin levels were associated with a reduced risk of developing GDM validating the work of Rasanen et al. Furthermore, there is evidence to suggest that adiponectin may also be used in predicting the development of post-partum glucose intolerance in women with a history of GDM [134]. The gene discussed is ADIPOQ; the disease is Glucose intolerance.